Cargando…

Steering a Course through the COVID-19 Pandemic: Should the SECURE-IBD Registry Influence Prescribing for Patients with Inflammatory Bowel Disease?

Detalles Bibliográficos
Autores principales:	Gomes, Catarina Frias, Chapman, Thomas, Satsangi, Jack, Torres, Joana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2021
Materias:	Selected Summaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843246/ https://www.ncbi.nlm.nih.gov/pubmed/33516701 http://dx.doi.org/10.1053/j.gastro.2021.01.216

Ejemplares similares

Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
por: Chapman, Thomas P., et al.
Publicado: (2021)

Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy
por: D’Amico, Ferdinando, et al.
Publicado: (2020)

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease
por: Spiera, Emily, et al.
Publicado: (2022)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

por: Talwar, Sachin
Publicado: (2011)

SELECTED SUMMARIES
por: Talwar, Sachin, et al.
Publicado: (2012)

Selected summaries
por: Kannan, B.R.J.
Publicado: (2008)

Selected summaries
por: Talwar, Sachin, et al.
Publicado: (2008)

SELECTED SUMMARIES
por: Kannan, Bhava RJ
Publicado: (2013)

Selected Summaries
por: Singhi, Anil Kumar, et al.
Publicado: (2014)

SELECTED SUMMARIES
por: Talwar, Sachin, et al.
Publicado: (2012)

SELECTED SUMMARIES
por: Kannan, Bhava RJ
Publicado: (2013)

Selected Summaries
por: Krishna, Mani Ram, et al.
Publicado: (2015)

Pediatric cardiac sciences 2015: A summary of significant publications
por: Viswanathan, Sangeetha, et al.
Publicado: (2016)

Novel Coronavirus Disease-2019 and the Gastrointestinal Tract: Lessons Learned from Human Organoids
por: Jurado-Gomez, Antonio, et al.
Publicado: (2020)

Acute Upper GI Bleeding: Good Night, Sleep Tight, Endoscopy Can Wait until Morning Light
por: Cader, M. Zaeem, et al.
Publicado: (2020)

Adding Fuel to the Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection
por: Antia, Avan, et al.
Publicado: (2022)

Gut Microbiome Composition Is Associated with COVID-19 Disease Severity
por: Patel, Pooja, et al.
Publicado: (2021)

Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
por: Trivedi, Mehul, et al.
Publicado: (2022)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Should photographic triage become common practice?
por: Thomas, Nicole
Publicado: (2021)

Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry
por: Torres, Esther A., et al.
Publicado: (2012)

Should we test asymptomatic children for SARS-CoV-2?
por: Cowan, Kirsty, et al.
Publicado: (2021)

Opioid Prescribing Behaviors — Prescription Behavior Surveillance System, 11 States, 2010–2016
por: Strickler, Gail K., et al.
Publicado: (2020)

The 16th Summer Intensive Course & the EACON 2018
por: Suh, Sangil, et al.
Publicado: (2018)

International Course on Emerging Viruses in the Amazon Region
por: Gomes, Ana Lisa do Vale, et al.
Publicado: (2009)

Saliva is a potential source of Covid-19, and appropriate protection measures should be applied in dental practice
por: Schwendicke, Falk
Publicado: (2020)

Intestinal Ultrasound in Inflammatory Bowel Disease: A Valuable and Increasingly Important Tool
por: Frias-Gomes, Catarina, et al.
Publicado: (2021)

How to Prescribe
Publicado: (1897)

Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015)

How should humanity steer the future?
por: Aguirre, Anthony, et al.
Publicado: (2016)

Schools as They Are and as They Should Be
por: Bullitt, H. M.
Publicado: (1847)

2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome
por: Chang, Lin, et al.
Publicado: (2016)

A practical guide to thiopurine prescribing and monitoring in IBD
por: Warner, Ben, et al.
Publicado: (2018)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Mwinyi, Jessica, et al.
Publicado: (2012)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015)

Closing remarks: Environmental health in the twenty-first century
por: Goldstein, Bernard D.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_r3loonpp2o1ic18prkhq0blaf8